Summary & Key Points
"Early on, the PAC-CI Programme focused on a major public health issue: mother-to-child transmission of HIV. At a time when access to treatment was still limited, this form of transmission was a significant concern for healthcare providers, families, and health systems."
PAC-CI has long prioritized child protection in its research
Early on, the PAC-CI Program focused on a major public health issue: mother-to-child transmission of HIV.
At a time when access to treatments remained limited, this form of transmission was a significant concern for healthcare providers, families, and health systems. Pregnancy, childbirth, and breastfeeding were particularly sensitive moments, requiring tailored responses to better protect newborns.
In the face of this challenge, PAC-CI chose to make child protection a key focus of its research. This commitment resulted in the conduct of two pioneering trials: DITRAME and DITRAME+.
Through these studies, the Program sought concrete solutions to better understand how to reduce the risk of mother-to-child HIV transmission in our context.
In our next article, discover how the DITRAME and DITRAME+ trials contributed to advancing strategies for preventing mother-to-child HIV transmission.
Christian Kouadio
Clinical Research Associate and Communications Manager at PAC-CI
Contact the author
